Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31758187 | 1.00 | PTPN1 (0.68) | PTPN1PTPN2 | |
| SCHEMBL31758184 | 0.91 | PTPN1 (0.67) | PTPN1PTPN2 | |
| SCHEMBL12009129 | 0.87 | PTPN1 (0.68) | PTPN1PTPN2 | |
| SCHEMBL2897202 | 0.83 | PTPN1 (0.63) | PTPN1PTPN2 | |
| SCHEMBL31758035 | 0.83 | PTPN1 (0.60) | PTPN1PTPN2 | |
| SCHEMBL3128181 | 0.82 | PTPN1 (0.61) | PTPN1PTPN2 | |
| SCHEMBL30705410 | 0.82 | PTPN1 (0.78) | PTPN1PTPN2 | |
| SCHEMBL12009130 | 0.82 | PTPN1 (0.98) | PTPN1PTPN2 | |
| SCHEMBL12009128 | 0.82 | PTPN1 (0.94) | PTPN1PTPN2 | |
| SCHEMBL25326795 | 0.81 | PTPN1 (0.61) | PTPN1PTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228476-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240228476-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228476-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | PTPN2, PTPN22, PTPN1 | PTPN1 3/4885PTPN2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.